Published in Antimicrob Agents Chemother on February 01, 2001
Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev (2004) 2.95
In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun (2007) 2.03
Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrob Agents Chemother (2003) 1.97
The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan. J Bacteriol (2002) 1.76
Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin Microbiol Rev (2012) 1.74
In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli. Antimicrob Agents Chemother (2010) 1.68
Pseudomonas aeruginosa-plant root interactions. Pathogenicity, biofilm formation, and root exudation. Plant Physiol (2003) 1.50
Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteins. J Bacteriol (2007) 1.36
BacMet: antibacterial biocide and metal resistance genes database. Nucleic Acids Res (2013) 1.35
Potential impact of increased use of biocides in consumer products on prevalence of antibiotic resistance. Clin Microbiol Rev (2003) 1.33
Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2005) 1.30
Substrate-dependent utilization of OprM or OpmH by the Pseudomonas aeruginosa MexJK efflux pump. Antimicrob Agents Chemother (2005) 1.29
Mutations in PA2491 (mexS) promote MexT-dependent mexEF-oprN expression and multidrug resistance in a clinical strain of Pseudomonas aeruginosa. J Bacteriol (2005) 1.29
Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J Clin Microbiol (2004) 1.27
Plasmid selection in Escherichia coli using an endogenous essential gene marker. BMC Biotechnol (2008) 1.25
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest (2004) 1.18
MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa: involvement in chlorhexidine resistance and induction by membrane-damaging agents dependent upon the AlgU stress response sigma factor. Antimicrob Agents Chemother (2008) 1.17
The biocide triclosan selects Stenotrophomonas maltophilia mutants that overproduce the SmeDEF multidrug efflux pump. Antimicrob Agents Chemother (2005) 1.17
Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump. Antimicrob Agents Chemother (2008) 1.15
The binding of triclosan to SmeT, the repressor of the multidrug efflux pump SmeDEF, induces antibiotic resistance in Stenotrophomonas maltophilia. PLoS Pathog (2011) 1.12
Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother (2004) 1.09
The impact of triclosan on the spread of antibiotic resistance in the environment. Front Microbiol (2015) 1.04
Exposure of sink drain microcosms to triclosan: population dynamics and antimicrobial susceptibility. Appl Environ Microbiol (2003) 1.01
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens. Antimicrob Agents Chemother (2009) 1.00
Inhibitory effect of biocides on the viable masses and matrices of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Appl Environ Microbiol (2010) 1.00
Effects of quaternary-ammonium-based formulations on bacterial community dynamics and antimicrobial susceptibility. Appl Environ Microbiol (2004) 0.99
Role of the MexAB-OprM efflux pump of Pseudomonas aeruginosa in tolerance to tea tree (Melaleuca alternifolia) oil and its monoterpene components terpinen-4-ol, 1,8-cineole, and alpha-terpineol. Appl Environ Microbiol (2008) 0.98
Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415. Antimicrob Agents Chemother (2005) 0.98
Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens. Int J Environ Res Public Health (2015) 0.96
Antibacterial cleaning products and drug resistance. Emerg Infect Dis (2005) 0.94
A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprM. J Bacteriol (2007) 0.93
Triclosan: current status, occurrence, environmental risks and bioaccumulation potential. Int J Environ Res Public Health (2015) 0.93
Molecular characterization of MexL, the transcriptional repressor of the mexJK multidrug efflux operon in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2005) 0.92
In vitro study of the effect of cationic biocides on bacterial population dynamics and susceptibility. Appl Environ Microbiol (2008) 0.91
Persistence of microbial communities including Pseudomonas aeruginosa in a hospital environment: a potential health hazard. BMC Microbiol (2014) 0.91
The use of machine learning methodologies to analyse antibiotic and biocide susceptibility in Staphylococcus aureus. PLoS One (2013) 0.89
High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: evidence from outbreak investigation. BMC Res Notes (2012) 0.88
Co-occurrence of resistance genes to antibiotics, biocides and metals reveals novel insights into their co-selection potential. BMC Genomics (2015) 0.88
Triclosan can select for an AdeIJK-overexpressing mutant of Acinetobacter baumannii ATCC 17978 that displays reduced susceptibility to multiple antibiotics. Antimicrob Agents Chemother (2014) 0.86
Characterization of pre-antibiotic era Klebsiella pneumoniae isolates with respect to antibiotic/disinfectant susceptibility and virulence in Galleria mellonella. Antimicrob Agents Chemother (2015) 0.85
Staphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates. PLoS One (2013) 0.84
Sublethal triclosan exposure decreases susceptibility to gentamicin and other aminoglycosides in Listeria monocytogenes. Antimicrob Agents Chemother (2011) 0.84
Reduced triclosan susceptibility in methicillin-resistant Staphylococcus epidermidis. Antimicrob Agents Chemother (2004) 0.84
Efficacy of surface disinfectant cleaners against emerging highly resistant gram-negative bacteria. BMC Infect Dis (2014) 0.83
Antimicrobial biocides in the healthcare environment: efficacy, usage, policies, and perceived problems. Ther Clin Risk Manag (2005) 0.83
Antimicrobial Activity of Medicated Soaps Commonly Used By Dar es Salaam Residents in Tanzania. Indian J Pharm Sci (2011) 0.83
Antibacterial activity of a triclosan-containing resin composite matrix against three common oral bacteria. J Mater Sci Mater Med (2010) 0.82
Efflux as a glutaraldehyde resistance mechanism in Pseudomonas fluorescens and Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother (2015) 0.82
The relative contribution of efflux and target gene mutations to fluoroquinolone resistance in recent clinical isolates of Pseudomonas aeruginosa. Eur J Clin Microbiol Infect Dis (2010) 0.81
Microbiological evaluation of the efficacy of two new biodetergents on multidrug-resistant nosocomial pathogens. Ann Clin Microbiol Antimicrob (2009) 0.81
nfxB as a novel target for analysis of mutation spectra in Pseudomonas aeruginosa. PLoS One (2013) 0.80
Can the antibiotic resistance of a microorganism predict decreased bactericidal efficacy of disinfectants? Application to OPA and other products. Eur J Clin Microbiol Infect Dis (2008) 0.80
Bacterial Multidrug Efflux Pumps: Much More Than Antibiotic Resistance Determinants. Microorganisms (2016) 0.79
Characterization of triclosan-resistant mutants reveals multiple antimicrobial resistance mechanisms in Rhodospirillum rubrum S1H. Appl Environ Microbiol (2010) 0.79
Antimicrobial Chemicals Are Associated with Elevated Antibiotic Resistance Genes in the Indoor Dust Microbiome. Environ Sci Technol (2016) 0.78
Triclosan Exposure Is Associated with Rapid Restructuring of the Microbiome in Adult Zebrafish. PLoS One (2016) 0.78
Effects of Formulation on Microbicide Potency and Mitigation of the Development of Bacterial Insusceptibility. Appl Environ Microbiol (2015) 0.78
Triclosan-induced modification of unsaturated fatty acid metabolism and growth in Pseudomonas aeruginosa PAO1. Curr Microbiol (2010) 0.78
Variable Effects of Exposure to Formulated Microbicides on Antibiotic Susceptibility in Firmicutes and Proteobacteria. Appl Environ Microbiol (2016) 0.77
Resistance-Nodulation-Division Multidrug Efflux Pumps in Gram-Negative Bacteria: Role in Virulence. Antibiotics (Basel) (2013) 0.77
Pentachlorophenol induction of the Pseudomonas aeruginosa mexAB-oprM efflux operon: involvement of repressors NalC and MexR and the antirepressor ArmR. PLoS One (2012) 0.77
Triclosan antagonizes fluconazole activity against Candida albicans. J Dent Res (2011) 0.76
Discovery of bacterial fatty acid synthase type II inhibitors using a novel cellular bioluminescent reporter assay. Antimicrob Agents Chemother (2015) 0.75
Predictive Studies Suggest that the Risk for the Selection of Antibiotic Resistance by Biocides Is Likely Low in Stenotrophomonas maltophilia. PLoS One (2015) 0.75
Effects of cetylpyridinium chloride resistance and treatment on fluconazole activity versus Candida albicans. Antimicrob Agents Chemother (2005) 0.75
Formulation of Biocides Increases Antimicrobial Potency and Mitigates the Enrichment of Non-Susceptible Bacteria in Multi-Species Biofilms. Appl Environ Microbiol (2017) 0.75
Antibacterial-coated suture in reducing surgical site infection in breast surgery: a prospective study. Int J Breast Cancer (2012) 0.75
Triclosan Resistome from Metagenome Reveals Diverse Enoyl Acyl Carrier Protein Reductases and Selective Enrichment of Triclosan Resistance Genes. Sci Rep (2016) 0.75
Complete Genome Sequence of the Triclosan- and Multidrug-Resistant Pseudomonas aeruginosa Strain B10W Isolated from Municipal Wastewater. Genome Announc (2017) 0.75
Effect of treatment with an overheated dry-saturated steam vapour disinfection system on multidrug and extensively drug-resistant nosocomial pathogens and comparison with sodium hypochlorite activity. BMC Res Notes (2015) 0.75
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature (2000) 32.30
Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev (1999) 10.44
Multidrug efflux pumps of gram-negative bacteria. J Bacteriol (1996) 9.86
Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J Bacteriol (1993) 8.95
Inactivation of antibiotics and the dissemination of resistance genes. Science (1994) 7.89
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1995) 6.65
Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol (1997) 5.91
Overexpression of the mexC-mexD-oprJ efflux operon in nfxB-type multidrug-resistant strains of Pseudomonas aeruginosa. Mol Microbiol (1996) 5.20
Cell-to-cell signaling and Pseudomonas aeruginosa infections. Emerg Infect Dis (1999) 4.75
Triclosan targets lipid synthesis. Nature (1998) 4.70
Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob Agents Chemother (1999) 4.57
Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression. Antimicrob Agents Chemother (1996) 3.86
Expression in Escherichia coli of a new multidrug efflux pump, MexXY, from Pseudomonas aeruginosa. Antimicrob Agents Chemother (1999) 3.76
In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob Agents Chemother (1999) 2.90
Broad spectrum antimicrobial biocides target the FabI component of fatty acid synthesis. J Biol Chem (1998) 2.75
Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother (1999) 2.74
Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother (2000) 2.67
A triclosan-resistant bacterial enzyme. Nature (2000) 2.40
Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexB-OprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob Agents Chemother (1998) 2.39
Chromosome mapping in Pseudomonas aeruginosa PAT. J Bacteriol (1978) 2.38
Mechanism of triclosan inhibition of bacterial fatty acid synthesis. J Biol Chem (1999) 2.34
Characterization of the MexC-MexD-OprJ multidrug efflux system in DeltamexA-mexB-oprM mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1998) 2.29
Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol Lett (1998) 2.24
Triclosan: applications and safety. Am J Infect Control (1996) 2.11
Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene. J Biol Chem (2000) 1.93
Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol (1999) 1.74
Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob Agents Chemother (1998) 1.68
Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan. Antimicrob Agents Chemother (1999) 1.67
Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect (1999) 1.49
Cloning and nucleotide sequence of the Pseudomonas aeruginosa nfxB gene, conferring resistance to new quinolones. FEMS Microbiol Lett (1992) 1.48
Origins and evolution of antibiotic resistance. Microbiologia (1996) 1.18
Investigations on the mode of action of Triclosan, a broad spectrum antimicrobial agent. Zentralbl Bakteriol Orig A (1974) 1.15
pH modification to enhance the molecular sieving properties of sodium dodecyl sulfate-10% polyacrylamide gels. Anal Biochem (1993) 1.14
An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa. Gene (1995) 5.18
Integration-proficient plasmids for Pseudomonas aeruginosa: site-specific integration and use for engineering of reporter and expression strains. Plasmid (2000) 4.67
Integration-proficient Pseudomonas aeruginosa vectors for isolation of single-copy chromosomal lacZ and lux gene fusions. Biotechniques (2000) 2.73
Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus. Infect Immun (1994) 2.36
Protective role of catalase in Pseudomonas aeruginosa biofilm resistance to hydrogen peroxide. Appl Environ Microbiol (1999) 1.99
Pseudomonas aeruginosa sodA and sodB mutants defective in manganese- and iron-cofactored superoxide dismutase activity demonstrate the importance of the iron-cofactored form in aerobic metabolism. J Bacteriol (1995) 1.99
Reverse sample genome probing, a new technique for identification of bacteria in environmental samples by DNA hybridization, and its application to the identification of sulfate-reducing bacteria in oil field samples. Appl Environ Microbiol (1991) 1.92
Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. J Bacteriol (1999) 1.74
Tobacco use in Vietnam. Prevalence, predictors, and the role of the transnational tobacco corporations. JAMA (1997) 1.48
Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther (2010) 1.45
Characterization of a Pseudomonas aeruginosa fatty acid biosynthetic gene cluster: purification of acyl carrier protein (ACP) and malonyl-coenzyme A:ACP transacylase (FabD). J Bacteriol (1999) 1.32
Molecular characterization of the tdc operon of Escherichia coli K-12. J Bacteriol (1988) 1.24
A novel membrane-associated threonine permease encoded by the tdcC gene of Escherichia coli. J Bacteriol (1990) 1.18
Down regulation of virulence factors of Pseudomonas aeruginosa by salicylic acid attenuates its virulence on Arabidopsis thaliana and Caenorhabditis elegans. Infect Immun (2005) 1.16
Involvement of GABA(A) receptors in myoclonus. Mov Disord (2000) 1.16
Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life. Aliment Pharmacol Ther (2012) 1.10
Cloning and sequence analysis of the fur gene encoding an iron-regulatory protein of Neisseria meningitidis. Gene (1994) 1.10
High-frequency flp recombinase-mediated inversions of the oriC-containing region of the Pseudomonas aeruginosa genome. J Bacteriol (2000) 1.09
PlcR1 and PlcR2 are putative calcium-binding proteins required for secretion of the hemolytic phospholipase C of Pseudomonas aeruginosa. Infect Immun (1997) 1.07
Molecular genetic analysis of the region containing the essential Pseudomonas aeruginosa asd gene encoding aspartate-beta-semialdehyde dehydrogenase. Microbiology (1997) 1.02
Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary clinical isolates of Pseudomonas aeruginosa. FEMS Microbiol Lett (2001) 0.96
Bacteriophage lambda DNA maturation. The functional relationships among the products of genes Nul, A and FI. J Mol Biol (1981) 0.96
Plant models for animal pathogenesis. Cell Microbiol (2005) 0.93
Utilization of a mini-Dlac transposable element to create an alpha-complementation and regulated expression system for cloning in Pseudomonas aeruginosa. Gene (1994) 0.89
ASD-GFP vectors for in vivo expression technology in Pseudomonas aeruginosa and other gram-negative bacteria. Biotechniques (1998) 0.86
Correlation of imaging techniques to histopathology in patients with diabetic foot syndrome and clinical suspicion of chronic osteomyelitis. The role of high-resolution ultrasound. Diabetes Care (1999) 0.85
Cloning and characterization of the Neisseria meningitidis asd gene. Gene (1993) 0.85
Synaptobrevin 2 is palmitoylated in synaptic vesicles prepared from adult, but not from embryonic brain. Mol Cell Neurosci (2000) 0.85
Vector design and development of host systems for Pseudomonas. Genet Eng (N Y) (2001) 0.83
Carbon-starvation induction of the ugp operon, encoding the binding protein-dependent sn-glycerol-3-phosphate transport system in Escherichia coli. Mol Gen Genet (1991) 0.82
Activity-dependent changes of the presynaptic synaptophysin-synaptobrevin complex in adult rat brain. Eur J Cell Biol (2001) 0.81
The N-terminal half of NPM dissociates from nucleoli of HeLa cells after anticancer drug treatments. Biochem Biophys Res Commun (1999) 0.80
Identification and genetic characterization of the Pseudomonas aeruginosa leuB gene encoding 3-isopropylmalate dehydrogenase. Mol Gen Genet (1997) 0.77
Quality of life and circadian variation of heart rate and heart rate variability in short-term survivors and nonsurvivors after acute myocardial infarction. Clin Cardiol (1993) 0.76
A Burkholderia pseudomallei colony variant necessary for gastric colonization. MBio (2015) 0.76
[Prevalence of caries, fissure sealants and filling materials among German children and children of migrants]. Gesundheitswesen (2004) 0.75
Design of bacterial hosts for lac-based expression vectors. Methods Mol Biol (1997) 0.75
[ONN THE STABILITY OF THE AMIDE GROUP OF L-N-acetylglutamine in water solution]. Arzneimittelforschung (1967) 0.75
[On the problem of utilization of infused amino acid solutions]. Klin Wochenschr (1967) 0.75
Testosterone metabolism in rabbits actively immunized with testosterone. Endocrinology (1976) 0.75
[Accuracy of the tablet pole used by the WHO to determine dosage of praziquantel in Vietnam]. Med Trop (Mars) (2008) 0.75